1. Liu, Jia, Cao, Feng, Li, Xiaojie, Lin, Jingrong, Han, Chuanchun. 2021. ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4. In Cell death & disease, 12, 438. doi:10.1038/s41419-021-03707-7. https://pubmed.ncbi.nlm.nih.gov/33935281/
2. Dittmann, Jessica, Ziegfeld, Angelique, Jansen, Lars, Dürst, Matthias, Backsch, Claudia. 2017. Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis. In Molecular carcinogenesis, 56, 1578-1589. doi:10.1002/mc.22613. https://pubmed.ncbi.nlm.nih.gov/28059468/
3. Rose, Michael, Kloten, Vera, Noetzel, Erik, Knüchel, Ruth, Dahl, Edgar. 2017. ITIH5 mediates epigenetic reprogramming of breast cancer cells. In Molecular cancer, 16, 44. doi:10.1186/s12943-017-0610-2. https://pubmed.ncbi.nlm.nih.gov/28231808/
4. Morcel, Karine, Watrin, Tanguy, Jaffre, Frédérique, Levêque, Jean, Guerrier, Daniel. . Involvement of ITIH5, a candidate gene for congenital uterovaginal aplasia (Mayer-Rokitansky-Küster-Hauser syndrome), in female genital tract development. In Gene expression, 15, 207-14. doi:. https://pubmed.ncbi.nlm.nih.gov/23539898/
5. Kloten, Vera, Rose, Michael, Kaspar, Sophie, Knüchel, Ruth, Dahl, Edgar. 2014. Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype. In Epigenetics, 9, 1290-301. doi:10.4161/epi.32089. https://pubmed.ncbi.nlm.nih.gov/25093535/
6. Rose, Michael, Meurer, Steffen K, Kloten, Vera, Knüchel, Ruth, Dahl, Edgar. 2017. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death. In Molecular carcinogenesis, 57, 167-181. doi:10.1002/mc.22742. https://pubmed.ncbi.nlm.nih.gov/28940371/
7. Kosinski, Jennifer, Sechi, Antonio, Hain, Johanna, Jonigk, Danny, Dahl, Edgar. 2024. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration. In Molecular oncology, 18, 1486-1509. doi:10.1002/1878-0261.13609. https://pubmed.ncbi.nlm.nih.gov/38375974/